Biomedizinische Forschung und Bio-Produkte

Biomedizinische Forschungs- und Bio-Produkte GmbH is a specialized biotechnology research firm based in Vienna, Austria, focusing on the development of advanced protein therapeutics. The company possesses deep expertise in the biochemistry of blood coagulation and plasma proteins, contributing significantly to the field of hematology. Its research activities primarily center on recombinant and plasma-derived proteins, including Factor VIII, Protein C, and von Willebrand factor. Historically, the entity and its leadership have been instrumental in the innovation pipeline that supports major pharmaceutical players in the hemophilia and thrombosis space. The company operates as a high-level R&D boutique, bridging the gap between academic discovery and industrial application. Its work is characterized by a strong emphasis on the molecular characterization and optimization of therapeutic proteins.